Adeno‐associated viral vector gene therapy: Challenges for the paediatric hepatologist
Authors:
Open Access
- 28 July 2024
- journal article
- review article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 79 (3) , 485-494
Abstract
Hepatoxicity associated with recombinant adeno‐associated virus gene therapy is being increasingly encountered by hepatologists in tertiary and quaternary referral units due to the recent increase of these therapies for neuromuscular and haematological disorders. The challenges in managing the condition stem from a lack of good‐quality evidence on the appropriate protocols for immunosuppressants due to lack of representative animal models. There is a need for protocols for diagnosing and treating hepatotoxicity and this possible with further research to understand the problem and its management. The review also highlights the importance of a multidisciplinary team in managing hepatotoxicity and recommends further research to better identify at‐risk individuals, define the extent of the problem and assess the long‐term effects of liver injury and immunosuppressants.Keywords
This publication has 59 references indexed in Scilit:
- Hepatotoxicity in Adeno-Associated Viral Vector Gene TherapyCurrent Hepatology Reports, 2023
- Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transferCellular Immunology, 2019
- Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectorsHepatology, 2017
- In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy VectorCell Reports, 2015
- Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risksEuropean Journal of Paediatric Neurology, 2012
- Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsHepatology, 2012
- Toll–Like Receptor 2–Mediated Innate Immune Response in Human Nonparenchymal Liver Cells Toward Adeno–Associated Viral VectorsHepatology, 2011
- Abnormal fatty acid metabolism in childhood spinal muscular atrophyAnnals of Neurology, 1999
- Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: Primary or secondary defect(s)?Pediatric Neurology, 1995
- Dicarboxylic aciduria in an infant with spinal muscular atrophyAnnals of Neurology, 1986